Recursion Pharmaceuticals CFO Offloads Shares Amid Market Volatility
Recursion Pharmaceuticals (NASDAQ: RXRX) continues to navigate a complex financial landscape, marked by recent insider trading activity and a stock price hovering near its yearly
Biotech Market Watch: Phathom Posts Earnings Beat While Medicus Holds Steady
Phathom Pharma Exceeds Expectations Phathom Pharma recently delivered a solid earnings surprise, beating EPS estimates by $0.34 and topping revenue forecasts. The stock closed regular
Indonesia Launches Locally Produced Cancer Therapies in Collaboration with BeiGene
PT Etana Biotechnologies Indonesia has officially introduced two new cancer treatment drugs—Etapidi (tislelizumab) and Brukinsa (zanubrutinib)—marking a significant milestone in the country’s healthcare landscape. The
MindMed Advances Clinical Pipeline in Brain Health Treatment
Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company based in New York City, continues its mission to develop innovative therapies for brain health disorders. Founded
ABL Bio and GSK Partner to Develop Treatments for Neurodegenerative Diseases Using Grabody-B Platform
ABL Bio Inc. (KOSDAQ: 298380), a biotechnology company specializing in bispecific antibodies for immuno-oncology and neurodegenerative diseases, has announced a global licensing agreement with pharmaceutical
Okeiro Raises €10 Million to Expand AI-Driven Precision Medicine Platform for Transplantation and Chronic Diseases
Okeiro, a French company specializing in precision medicine for transplantation and advanced chronic diseases, has announced a €10 million funding round to support its growth
Palmas Strengthens Public Healthcare with Investments in Infrastructure, Medications, and Staffing
In the first 100 days of the new administration, the Palmas City Hall has made healthcare one of its top priorities. Under the leadership of
Deutsche Bahn Shifts Focus: Kiosk Brand “ServiceStore DB” to Be Phased Out by 2026
Deutsche Bahn (DB) has announced its decision to exit the kiosk business at German train stations, marking another step in its ongoing modernization strategy. The
Universe Pharmaceuticals Stock Plunges to 52-Week Low Amid Mounting Challenges
Universe Pharmaceuticals Inc. is facing increasing financial pressure as its stock has dropped to a new 52-week low of just $3.20. The sharp decline reflects
Hyundai Insteroid: A Video Game Dream on Wheels
Hyundai has unveiled a bold new design concept called the Insteroid, transforming its modest compact EV, the Inster, into a futuristic fusion of race car